However, BT was more prevalent in patients with NAFLD (29.7% vs 13.7%; p < 0.001), who had higher values of TNF-α, Il-6, IL-17, IL-23, and TGF-β than those with NAFLD but without BT (p < 0.001). Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.